ArticleThe Lancet. Rheumatology2020

Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?

Su-Ann Yeoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.